NIPH Sekvenace.cz

Česky


Project CZ0127 funded by the FM EEA/Norway and public funds of the Czech Republic eea grants

Sequence characterization of selected bacterial agents
causing serious diseases in the Czech Republic


Contact


Project coordinator

Pavla Křížová, MD, PhD – Head of the Unit of Airborne Bacterial Infections, Centre of Public Health Laboratories, National Institute of Public Health, Head of the National Reference Laboratory for Meningococcal Infections and Head of the WHO Collaborating Centre for Reference and Research on Streptococci.

e-mail: pavla.krizova@szu.cz


External collaboration

Clinical microbiology laboratories from all over the Czech Republic refer isolates from current cases of serious infections and their contacts to the National reference laboratories of the investigator team for confirmation and further characterization by advanced methods. The reference laboratories provide the obtained characterization data to the field laboratories.


Investigator team

The investigator institution is the National Institute of Public Health (NIPH), Šrobárova 48, Prague 10, Czech Republic

The investigator laboratories are three national reference laboratories of NIPH:

The National Reference Laboratories are accreditted by the Czech Accreditation Institute (CAI). They are holders of the International Accreditation Certificates according to ČSN EN ISO 15189 and ČSN EN ISO/IEC 17025:2005. These certificates are audited by CAI on a regular basis.

NIPH participates in regular international quality controls. It has been involved in the external quality assessment (EQA) schemes for clinical microbiology laboratories in the Czech Republic. It has a good tradition of successful completion of grant projects at both the national and European levels. Within the international collaboration, NIPH contributes to worldwide databases of detailed characterization of selected bacterial agents that enable global analyses of causative agents of serious infectious diseases. The results are helpful in the development of more effective gene technology based vaccines.


xhtml 1.1 css 2.1 rss 2.0 Atelier GINGO

© 2008 SZÚ